Search keyWord :

"Bleach: Brave Souls" New Year Special - Thousand-Year Blood War Zenith Summons: Fervor to Begin Alongside a Gift Campaign with Prizes Like an Xbox & Brave Souls Original Merch

Jan 3, 2025

TOKYO,Dec. 27,2024-- KLab Inc.,a leader in online mobile games,announced that its hit 3D action game Bleach: Brave Souls will be holding the New Year Special - Thousand-Year Blood War Zenith Summons:

CASEKOO Unveils New X Series Phone Cases with Enchanting "RoseParade" Theme

Jan 3, 2025

LOS ANGELES,Dec. 27,2024-- CASEKOO a trailblazer in premium smartphone accessories,is proud to announce the unveiling of its highly anticipated new X Series phone cases,breathing new life into the s

CBAK Energy Technology, Inc. Announces Significant Orders from Anker Innovations, totaling around USD 30 Million to 35 Million

Jan 3, 2025

DALIAN,China,Dec. 27,2024-- CBAK Energy Technology,Inc. (NASDAQ: CBAT) ("CBAK Energy" or the "Company"),a leading manufacturer of lithium-ion and sodium-ion batteries and electric

EQT to Exit Indian Renewable Energy Platform O2 Power

Jan 3, 2025

EQT and Temasek to sell O2 Power to JSW Neo Energy for USD 1.5 billion. O2 Power was established as a new company in 2020 by EQT and Temasek and has since grown to become a leading player in India\'s

Sobot Redefines Service Excellence at the 2024 Customer Conference

Jan 3, 2025

Elevating Customer Experience from \'Good\' to \'Excellent\' Through Comprehensive Support SINGAPORE,Dec. 30,2024--Sobot hosted its annual customer conference in Singapore this December,where custome

To promote world peace, stability, and common progress of humanity

Jan 3, 2025

BEIJING,Dec. 30,2024--A report from People\'s Daily: "The Vision of Building a Community with a Shared Future for Mankind carries forward the same spirit of the Five Principles of Peaceful Coexis

Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726

Jan 3, 2025

SUZHOU,China,Dec. 30,2024-- Hangzhou Sino-US Huadong Medicine Co.,Ltd. (hereinafter referred to as "Huadong Medicine"),a wholly-owned subsidiary of Huadong Medicine Co.,Ltd. (SZ.000963),and

Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration

Jan 3, 2025

Introducing Hyaluronic Acid,Exosomes,and PDRN SEOUL,South Korea,Dec. 30,2024-- Maypharm Co.,Ltd.,a leading innovator in medical and dermo-cosmetic products,proudly introduces the global launch of Hyal

Taiwanese Companies Lead Innovation in AI-Powered Smart Wearables

Jan 3, 2025

TAIPEI,Dec. 30,2024--In the rapidly evolving tech landscape,smart wearable devices enriched with artificial intelligence (AI) and augmented reality (AR) are redefining the boundaries of innovation. Le

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

Jan 3, 2025

SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation

1 ... 528 529 530 531 532 533 534 ... 1285